Fibromyalgia research is progressing as scientists better understand the drivers of chronic pain and regulators push for non-narcotic solutions. The January approval of Journavx, ...
Evan Coleman is an Updates Editor on the Credit Cards and Travel Rewards team at Forbes Advisor, showcasing his interest in personal finance and love of travel. He has written for a variety of local ...
Tonix Pharma is preparing to launch the first new therapy for fibromyalgia in the US in 16 years, after claiming FDA approval for Tonmya, an oral drug used to treat the pain associated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback